Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Tax Provisions (2020 - 2025)

Historic Tax Provisions for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to -$92000.0.

  • Maravai Lifesciences Holdings' Tax Provisions fell 12958.2% to -$92000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.2 million, marking a year-over-year decrease of 10055.28%. This contributed to the annual value of -$1.9 million for FY2024, which is 10024.6% down from last year.
  • Maravai Lifesciences Holdings' Tax Provisions amounted to -$92000.0 in Q3 2025, which was down 12958.2% from -$4.3 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Tax Provisions ranged from a high of $766.2 million in Q4 2023 and a low of -$5.5 million during Q3 2023
  • Moreover, its 5-year median value for Tax Provisions was $311000.0 (2024), whereas its average is $45.9 million.
  • Within the past 5 years, the most significant YoY rise in Maravai Lifesciences Holdings' Tax Provisions was 897029.71% (2023), while the steepest drop was 13870.3% (2023).
  • Maravai Lifesciences Holdings' Tax Provisions (Quarter) stood at $17.6 million in 2021, then crashed by 51.95% to $8.4 million in 2022, then surged by 8970.3% to $766.2 million in 2023, then plummeted by 100.0% to -$7000.0 in 2024, then tumbled by 1214.29% to -$92000.0 in 2025.
  • Its last three reported values are -$92000.0 in Q3 2025, -$4.3 million for Q2 2025, and $162000.0 during Q1 2025.